Surgical feasibility and biocompatibility of the OptoEpiret retinal stimulator

Published on Jul 22, 2019in Investigative Ophthalmology & Visual Science3.47
Tibor Karl Lohmann4
Estimated H-index: 4
(RWTH Aachen University),
Cláudia Werner24
Estimated H-index: 24
(RWTH Aachen University)
+ 7 AuthorsKim Schaffrath3
Estimated H-index: 3
(RWTH Aachen University)
Cited By1
#1Victor Wang (UR: University of Rochester)H-Index: 1
#2Ajay E. Kuriyan (Thomas Jefferson University)H-Index: 2
Purpose of review The goal is providing an update to the latest research surrounding optoelectronic devices, highlighting key studies and benefits and limitations of each device. Recent Findings The Argus II demonstrated long-term safety after five-year follow-up. Due to lack of tack fixation, subretinal implants appear to displace over time. PRIMA's completed primate trial showed initial safety and potential for improved vision, resulting in ongoing clinical trials Bionic Vision Australia devel...
2 CitationsSource